{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:27:00Z","timestamp":1783423620716,"version":"3.54.6"},"reference-count":50,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Health Research Institutes, Taiwan","award":["IV-109-PP-11"],"award-info":[{"award-number":["IV-109-PP-11"]}]},{"name":"National Health Research Institutes, Taiwan","award":["110-2327-B-400-002"],"award-info":[{"award-number":["110-2327-B-400-002"]}]},{"name":"National Health Research Institutes, Taiwan","award":["111-2327-B-400-003"],"award-info":[{"award-number":["111-2327-B-400-003"]}]},{"name":"National Health Research Institutes, Taiwan","award":["112-2823-8-400-001"],"award-info":[{"award-number":["112-2823-8-400-001"]}]},{"name":"National Science and Technology Council, Taiwan","award":["IV-109-PP-11"],"award-info":[{"award-number":["IV-109-PP-11"]}]},{"name":"National Science and Technology Council, Taiwan","award":["110-2327-B-400-002"],"award-info":[{"award-number":["110-2327-B-400-002"]}]},{"name":"National Science and Technology Council, Taiwan","award":["111-2327-B-400-003"],"award-info":[{"award-number":["111-2327-B-400-003"]}]},{"name":"National Science and Technology Council, Taiwan","award":["112-2823-8-400-001"],"award-info":[{"award-number":["112-2823-8-400-001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Influenza viruses can cause highly infectious respiratory diseases, posing noteworthy epidemic and pandemic threats. Vaccination is the most cost-effective intervention to prevent influenza and its complications. However, reliance on embryonic chicken eggs for commercial influenza vaccine production presents potential risks, including reductions in efficacy due to HA gene mutations and supply delays due to scalability challenges. Thus, alternative platforms are needed urgently to replace egg-based methods and efficiently meet the increasing demand for vaccines. In this study, we employed a baculovirus expression vector system to engineer HA, NA, and M1 genes from seasonal influenza strains A\/H1N1, A\/H3N2, B\/Yamagata, and B\/Victoria, generating virus-like particle (VLP) vaccine antigens, H1N1-VLP, H3N2-VLP, Yamagata-VLP, and Victoria-VLP. We then assessed their functional and antigenic characteristics, including hemagglutination assay, protein composition, morphology, stability, and immunogenicity. We found that recombinant VLPs displayed functional activity, resembling influenza virions in morphology and size while maintaining structural integrity. Comparative immunogenicity assessments in mice showed that our quadrivalent VLPs were consistent in inducing hemagglutination inhibition and neutralizing antibody titers against homologous viruses compared to both commercial recombinant HA and egg-based vaccines (Vaxigrip). The findings highlight insect cell-based VLP vaccines as promising candidates for quadrivalent seasonal influenza vaccines. Further studies are worth conducting.<\/jats:p>","DOI":"10.3390\/vaccines12060667","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T11:14:16Z","timestamp":1718622856000},"page":"667","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Insect Cell-Based Quadrivalent Seasonal Influenza Virus-like Particles Vaccine Elicits Potent Immune Responses in Mice"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2821-0424","authenticated-orcid":false,"given":"A. T. M.","family":"Badruzzaman","sequence":"first","affiliation":[{"name":"National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes (NHRI), 35 Keyan Road, Zhunan  350, Taiwan"},{"name":"Department of Life Sciences, National Central University, Zhongli District, Taoyuan 320, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chieh","family":"Cheng","sequence":"additional","affiliation":[{"name":"National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes (NHRI), 35 Keyan Road, Zhunan  350, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3445-6036","authenticated-orcid":false,"given":"Wang-Chou","family":"Sung","sequence":"additional","affiliation":[{"name":"National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes (NHRI), 35 Keyan Road, Zhunan  350, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Shi","family":"Lee","sequence":"additional","affiliation":[{"name":"National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes (NHRI), 35 Keyan Road, Zhunan  350, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2023). Influenza (Seasonal)."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1016\/S2214-109X(19)30545-5","article-title":"Global Burden of Respiratory Infections Associated with Seasonal Influenza in Children under 5 Years in 2018: A Systematic Review and Modelling Study","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Kaaijk, P., Swaans, N., Nicolaie, A.M., Bruin, J.P., van Boxtel, R.A.J., de Lange, M.M.A., Meijer, A., Sanders, E.A.M., van Houten, M.A., and Rots, N.Y. (2022). Contribution of Influenza Viruses, Other Respiratory Viruses and Viral Co-Infections to Influenza-Like Illness in Older Adults. Viruses, 14.","DOI":"10.3390\/v14040797"},{"key":"ref_4","unstructured":"Centers for Disease Control and Prevention (2022). 2021\u20132022 U.S. Flu Season: Preliminary in-Season Burden Estimates."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.37201\/req\/159.2021","article-title":"The Victoria and Yamagata Lineages of Influenza B Viruses, Unknown and Undervalued","volume":"35","author":"Reina","year":"2022","journal-title":"Rev. Esp. Quimioter."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/irv.12319","article-title":"Epidemiological and Virological Characteristics of Influenza B: Results of the Global Influenza B Study","volume":"9","author":"Caini","year":"2015","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Skowronski, D.M., Janjua, N.Z., De Serres, G., Sabaiduc, S., Eshaghi, A., Dickinson, J.A., Fonseca, K., Winter, A.L., Gubbay, J.B., and Krajden, M. (2014). Low 2012-13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3n2 Vaccine Strain Not Antigenic Drift in Circulating Viruses. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0092153"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41423-022-00897-8","article-title":"Virus-Like Particle Vaccinology, from Bench to Bedside","volume":"19","author":"Mohsen","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.vaccine.2020.12.018","article-title":"Global Production Capacity of Seasonal and Pandemic Influenza Vaccines in 2019","volume":"39","author":"Sparrow","year":"2021","journal-title":"Vaccine"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Chen, J.R., Liu, Y.M., Tseng, Y.C., and Ma, C. (2020). Better Influenza Vaccines: An Industry Perspective. J. Biomed. Sci., 27.","DOI":"10.1186\/s12929-020-0626-6"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hong, Q., Liu, J., Wei, Y., and Wei, X. (2023). Application of Baculovirus Expression Vector System (Bevs) in Vaccine Development. Vaccines, 11.","DOI":"10.3390\/vaccines11071218"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Tariq, H., Batool, S., Asif, S., Ali, M., and Abbasi, B.H. (2021). Virus-Like Particles: Revolutionary Platforms for Developing Vaccines against Emerging Infectious Diseases. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.790121"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A Simple Method of Estimating Fifty Percent Endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Epidemiol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lai, C.C., Cheng, Y.C., Chen, P.W., Lin, T.H., Tzeng, T.T., Lu, C.C., Lee, M.S., and Hu, A.Y. (2019). Process Development for Pandemic Influenza Vlp Vaccine Production Using a Baculovirus Expression System. J. Biol. Eng., 13.","DOI":"10.1186\/s13036-019-0206-z"},{"key":"ref_15","unstructured":"ThermoFisher (2018). User Guide: Bac-to-Bac\u00ae Baculovirus Expression System, ThermoFisher."},{"key":"ref_16","unstructured":"World Health Organization (2024, June 11). Who Manual on Animal Influenza Virus Diagnosis and Surveilance, Available online: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/68026\/WHO_CDS?sequence=1."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0092-1157(77)80008-5","article-title":"An Improved Single-Radial-Immunodiffusion Technique for the Assay of Influenza Haemagglutinin Antigen: Application for Potency Determinations of Inactivated Whole Virus and Subunit Vaccines","volume":"5","author":"Wood","year":"1977","journal-title":"J. Biol. Stand."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2021.02.001","article-title":"A Modified Vaccinia Ankara Vector-Based Vaccine Protects Macaques from SARS-Cov-2 Infection, Immune Pathology, and Dysfunction in the Lungs","volume":"54","author":"Routhu","year":"2021","journal-title":"Immunity"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chia, M.Y., Hu, A.Y., Tseng, Y.F., Weng, T.C., Lai, C.C., Lin, J.Y., Chen, P.L., Wang, Y.F., Chao, S.R., and Chang, J.Y. (2015). Evaluation of Mdck Cell-Derived Influenza H7n9 Vaccine Candidates in Ferrets. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0120793"},{"key":"ref_20","unstructured":"World Health Organization (2005). Who Expert Comittee on Biological Standartisation Recommendations for the Production and Control of Influenza Vaccine (Inactivated)."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Zeng, Z., Yau, L.F., Lin, Z., Xia, X., Yang, Z., Wang, J.R., Song, W., and Wang, X. (2020). Characterization and Evolutionary Analysis of a Novel H3n2 Influenza a Virus Glycosylation Motif in Southern China. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01318"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/JCM.03575-13","article-title":"Detection of Nonhemagglutinating Influenza a(H3) Viruses by Enzyme-Linked Immunosorbent Assay in Quantitative Influenza Virus Culture","volume":"52","author":"Els","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1038\/s41467-021-25713-1","article-title":"Glycan Remodeled Erythrocytes Facilitate Antigenic Characterization of Recent a\/H3n2 Influenza Viruses","volume":"12","author":"Broszeit","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Correia, R., Fernandes, B., Alves, P.M., Carrondo, M.J.T., and Roldao, A. (2020). Improving Influenza Ha-Vlps Production in Insect High Five Cells Via Adaptive Laboratory Evolution. Vaccines, 8.","DOI":"10.3390\/vaccines8040589"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"785975","DOI":"10.3389\/fimmu.2022.785975","article-title":"Supplementation of H7n9 Virus-Like Particle Vaccine with Recombinant Epitope Antigen Confers Full Protection against Antigenically Divergent H7n9 Virus in Chickens","volume":"13","author":"Kong","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12033-010-9268-3","article-title":"Trichoplusia Ni Cells (High Five) Are Highly Efficient for the Production of Influenza a Virus-Like Particles: A Comparison of Two Insect Cell Lines as Production Platforms for Influenza Vaccines","volume":"45","author":"Krammer","year":"2010","journal-title":"Mol. Biotechnol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Matsuda, T., Tanijima, T., Hirose, A., Masumi-Koizumi, K., Katsuda, T., and Yamaji, H. (2020). Production of Influenza Virus-Like Particles Using Recombinant Insect Cells. Biochem. Eng. J., 163.","DOI":"10.1016\/j.bej.2020.107757"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6857","DOI":"10.1016\/j.vaccine.2019.09.057","article-title":"Influenza a and B Virus-Like Particles Produced in Mammalian Cells Are Highly Immunogenic and Induce Functional Antibodies","volume":"37","author":"Buffin","year":"2019","journal-title":"Vaccine"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.7774\/cevr.2020.9.2.126","article-title":"Influence of Temperature on the Antigenic Changes of Virus-Like Particles","volume":"9","author":"Shin","year":"2020","journal-title":"Clin. Exp. Vaccine Res."},{"key":"ref_30","unstructured":"Australian Government Department of Health (2019). National Vaccine Storage Guidelines\u2014Strive for 5."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"252","DOI":"10.7774\/cevr.2021.10.3.252","article-title":"Evaluation of the Antigenic Stability of Influenza Virus Like Particles after Exposure to Acidic or Basic Ph","volume":"10","author":"Kim","year":"2021","journal-title":"Clin. Exp. Vaccine Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/1743-422X-9-210","article-title":"Stability Studies of Hiv-1 Pr55gag Virus-Like Particles Made in Insect Cells after Storage in Various Formulation Media","volume":"9","author":"Lynch","year":"2012","journal-title":"Virol. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1016\/j.vaccine.2021.04.033","article-title":"Improved Storage of Influenza Ha-Vlps Using a Trehalose-Glycerol Natural Deep Eutectic Solvent System","volume":"39","author":"Correia","year":"2021","journal-title":"Vaccine"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.provac.2010.03.004","article-title":"Influenza Immunization with Trehalose-Stabilized Virus-Like Particle Vaccine Using Microneedles","volume":"2","author":"Kim","year":"2010","journal-title":"Procedia Vaccinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jps.22304","article-title":"H1n1 Influenza Virus-Like Particles: Physical Degradation Pathways and Identification of Stabilizers","volume":"100","author":"Kissmann","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1128\/CVI.00251-13","article-title":"Long-Term Protective Immunity from an Influenza Virus-Like Particle Vaccine Administered with a Microneedle Patch","volume":"20","author":"Quan","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hu, J., Zhang, Q., Peng, P., Li, R., Li, J., Wang, X., Gu, M., Hu, Z., Hu, S., and Liu, X. (2022). Baculovirus-Derived Influenza Virus-Like Particle Confers Complete Protection against Lethal H7n9 Avian Influenza Virus Challenge in Chickens and Mice. Vet. Microbiol., 264.","DOI":"10.1016\/j.vetmic.2021.109306"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.vaccine.2015.03.009","article-title":"Recombinant Virus-Like Particles Elicit Protective Immunity against Avian Influenza a(H7n9) Virus Infection in Ferrets","volume":"33","author":"Liu","year":"2015","journal-title":"Vaccine"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mai, Z., Cai, M., Hu, X., Li, M., Ji, Y., Li, S., Huang, J., Liang, Q., Ji, C., and Yi, H. (2023). Protection Efficacy of the H1 and H3 Bivalent Virus-Like Particle Vaccine against Swine Influenza Virus Infection. Vet. Microbiol., 280.","DOI":"10.1016\/j.vetmic.2023.109719"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biologicals.2009.02.014","article-title":"Flublok, a Next Generation Influenza Vaccine Manufactured in Insect Cells","volume":"37","author":"Cox","year":"2009","journal-title":"Biologicals"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2051013615595595","article-title":"Safety, Efficacy, and Immunogenicity of Flublok in the Prevention of Seasonal Influenza in Adults","volume":"3","author":"Cox","year":"2015","journal-title":"Ther. Adv. Vaccines"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.vaccine.2009.10.037","article-title":"Comparative Immunogenicity of Recombinant Influenza Hemagglutinin (Rha) and Trivalent Inactivated Vaccine (Tiv) among Persons > or =65 Years Old","volume":"28","author":"Keitel","year":"2009","journal-title":"Vaccine"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1080\/21645515.2016.1219809","article-title":"Immunogenicity of As03-Adjuvanted and Non-Adjuvanted Trivalent Inactivated Influenza Vaccines in Elderly Adults: A Phase 3, Randomized Trial and Post-Hoc Correlate of Protection Analysis","volume":"12","author":"Beran","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.297.14.1577","article-title":"Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza Vaccine: A Randomized Controlled Trial","volume":"297","author":"Treanor","year":"2007","journal-title":"JAMA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.virol.2017.08.023","article-title":"Live Baculovirus Acts as a Strong B and T Cell Adjuvant for Monomeric and Oligomeric Protein Antigens","volume":"511","author":"Heinimaki","year":"2017","journal-title":"Virology"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.vaccine.2021.01.004","article-title":"Phase Iii: Randomized Observer-Blind Trial to Evaluate Lot-to-Lot Consistency of a New Plant-Derived Quadrivalent Virus Like Particle Influenza Vaccine in Adults 18\u201349 Years of Age","volume":"39","author":"Ward","year":"2021","journal-title":"Vaccine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/infdis\/jix478","article-title":"Randomized Comparison of Immunogenicity and Safety of Quadrivalent Recombinant Versus Inactivated Influenza Vaccine in Healthy Adults 18\u201349 Years of Age","volume":"216","author":"Dunkle","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Rockman, S., Laurie, K., Ong, C., Rajaram, S., McGovern, I., Tran, V., and Youhanna, J. (2022). Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness. Vaccines, 11.","DOI":"10.3390\/vaccines11010052"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Rajaram, S., Suphaphiphat, P., van Boxmeer, J., Haag, M., Leav, B., Iheanacho, I., Kistler, K., and Ortiz de Lejarazu, R. (2020). Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002\u20132003 to 2017\u20132018. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17155423"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.vaccine.2020.06.021","article-title":"The Impact of Candidate Influenza Virus and Egg-Based Manufacture on Vaccine Effectiveness: Literature Review and Expert Consensus","volume":"38","author":"Rajaram","year":"2020","journal-title":"Vaccine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/6\/667\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:59:46Z","timestamp":1760108386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/6\/667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["vaccines12060667"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12060667","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]}}}